SCHEMBL6199205

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL6200243	0.89	MCL1 (0.45)	TUBBCA2CA4MCL1EGLN1
	SCHEMBL6222777	0.88	TUBB (0.46)	TUBBCA2MCL1EGLN1KCNA5
	SCHEMBL6196000	0.88	TUBB (0.45)	TUBBMCL1EGLN1KCNA5LMNA
	SCHEMBL6199057	0.87	TUBB (0.50)	TUBBCA2MCL1EGLN1LMNA
	SCHEMBL6199564	0.86	TUBB (0.46)	TUBBCA2MCL1EGLN1KCNA5
	SCHEMBL6197450	0.84	EGLN1 (0.43)	TUBBCA2MCL1EGLN1KCNA5
	SCHEMBL6198214	0.83	SMN1; SMN2 (0.51)	TUBBMCL1EGLN1LMNAALDH1A1
	SCHEMBL6198579	0.83	TUBB (0.46)	TUBBMCL1EGLN1POLBGRIN1
	SCHEMBL6197441	0.83	NAMPT (0.49)	TUBBMCL1EGLN1POLBMEN1
	SCHEMBL6200208	0.83	TUBB (0.46)	TUBBCA2MCL1EGLN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.